Rockwell Medical Technologies Receives Patent Grant for Proprietary SFP Iron-Delivery in Mexico

WIXOM, Mich., Oct. 23, 2007 (PRIME NEWSWIRE) -- Rockwell Medical Technologies, Inc. (Nasdaq:RMTI), a leading, innovative manufacturer and developer of renal drug therapies and essential dialysate products, focused on the end-stage-renal-disease (ESRD) market, reported that a Mexican patent was granted for its proprietary drug, Soluble Ferric Pyrophosphate (SFP). The Mexican SFP patent grant covers the method and pharmaceutical composition for iron delivery administered in hemodialysis and peritoneal dialysis patients.